Author correction to ‘A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease’ [Acta Pharmaceutica Sinica B 12 (2021) 4032‒4044]

Ting Lei,Zhihang Yang,Xue Xia,Yuxiu Chen,Xiaotong Yang,Rou Xie,Fan Tong,Xiaolin Wang,Huile Gao

DOI: https://doi.org/10.1016/j.apsb.2022.04.008

IF: 14.903

2022-04-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.04.022.].

pharmacology & pharmacy

What problem does this paper attempt to address?

Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Yang Han,Chunhong Gao,Hao Wang,Jiejie Sun,Meng Liang,Ye Feng,Qianqian Liu,Shiyao Fu,Lin Cui,Chunsheng Gao,Yi Li,Yang Yang,Baoshan Sun

DOI: https://doi.org/10.1016/j.bioactmat.2021.06.002

IF: 18.9

2022-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2020.08.017.].

engineering, biomedical,materials science, biomaterials
Correction: Application of Carbon-Based Nanomaterials in Alzheimer's Disease.

Mengyao Bai,Xu Shao,Chao Wang,Juanxia Wang,Xin Wang,Ping Guan,Xiaoling Hu

DOI: https://doi.org/10.1039/d4mh90125h

IF: 13.3

2024-01-01

Materials Horizons

Abstract:Correction for 'Application of carbon-based nanomaterials in Alzheimer's disease' by Mengyao Bai et al., Mater. Horiz., 2024, https://doi.org/10.1039/D4MH01256A.
Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

Xiongjie Fu,Hanhai Zeng,Jikuang Zhao,Guoyang Zhou,Hang Zhou,Jianfeng Zhuang,Chaoran Xu,Jianru Li,Yucong Peng,Yang Cao,Yin Li,Huaijun Chen,Lin Wang,Feng Yan,Gao Chen

DOI: https://doi.org/10.1007/s12975-021-00919-z

2021-01-01

Translational Stroke Research

Abstract:Correction to this paper has been published: https://doi.org/10.1007/s12975-021-00919-z
Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747]

Bo Xiao,Yuqi Liang,Ga Liu,Lingshuang Wang,Zhan Zhang,Libin Qiu,Haiting Xu,Sean Carr,Xiaoxiao Shi,Rui L Reis,Subhas C Kundu,Zhenhua Zhu

DOI: https://doi.org/10.1016/j.apsb.2024.06.005

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2024.02.008.].
Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Zekun Li,Yongchun Pan,Shizheng Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qiang Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Yi Qian,Meimei Zhao,Qinghua Han,Jingkang Wang,Lixi Liao,Heng Yang,Dan Liu,Pengfei Tu,Hong Liang,Kewu Zeng

DOI: https://doi.org/10.1016/j.apsb.2024.02.013

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.01.011.].
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35

Mengying Wei,Yuanyuan Liu,Zifeng Pi,Kexin Yue,Shizhe Li,Mingxin Hu,Zhiqiang Liu,Fengrui Song,Zhongying Liu

DOI: https://doi.org/10.1039/d1ra90081a

IF: 4.036

2021-01-01

RSC Advances

Abstract:Correction for ‘Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35’ by Mengying Wei et al. , RSC Adv. , 2019, 9 , 18308–18319. DOI: 10.1039/C9RA00302A.

chemistry, multidisciplinary
Corrigendum to “tanshinone IIA Alleviates CCL2-Induced Leaning Memory and Cognition Impairment in Rats: A Potential Therapeutic Approach for HIV-Associated Neurocognitive Disorder”

Yuan-jun Liao,Jian-min Chen,Jiang-yi Long,Yi-jun Zhou,Bing-yu Liang,Yan Zhou

DOI: https://doi.org/10.1155/2020/5834542

2020-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/2702175.].
Corrigendum: Microglia Mediate the Occurrence and Development of Alzheimer's Disease Through Ligand-Receptor Axis Communication

Chongdong Jian,Lei Wei,Ruikang Mo,Rongjie Li,Lucong Liang,Liechun Chen,Chun Zou,Youshi Meng,Ying Liu,Donghua Zou

DOI: https://doi.org/10.3389/fnagi.2021.800761

IF: 4.8

2021-11-19

Frontiers in Aging Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnagi.2021.731180.].

neurosciences,geriatrics & gerontology,gerontology
Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471]

Qiang Niu,Yu Liu,Yujing Zheng,Ziwei Tang,Yuna Qian,Ruogu Qi,Jianliang Shen,Ping Zhao

DOI: https://doi.org/10.1016/j.apsb.2024.02.021

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.11.002.].
Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Wan Li,Liwen Ren,Xiangjin Zheng,Jinyi Liu,Jinhua Wang,Tengfei Ji,Guanhua Du

DOI: https://doi.org/10.1016/j.apsb.2024.04.025

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2019.12.012.].
Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Yifeng Xia,Jingnan An,Jiaying Li,Wenxing Gu,Yifan Zhang,Songsong Zhao,Cenzhu Zhao,Yang Xu,Bin Li,Zhiyuan Zhong,Fenghua Meng

DOI: https://doi.org/10.1016/j.bioactmat.2023.08.011

IF: 18.9

2024-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].
Author Correction: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy

Xiaoying Chen,Maria Firulyova,Melissa Manis,Jasmin Herz,Igor Smirnov,Ekaterina Aladyeva,Chanung Wang,Xin Bao,Mary Beth Finn,Hao Hu,Irina Shchukina,Min Woo Kim,Carla M. Yuede,Jonathan Kipnis,Maxim N. Artyomov,Jason D. Ulrich,David M. Holtzman

DOI: https://doi.org/10.1038/s41586-024-08200-7

IF: 64.8

2024-10-17

Nature

Abstract:Nature, Published online: 16 October 2024; doi:10.1038/s41586-024-08200-7 Author Correction: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy

multidisciplinary sciences
Author Correction to ‘mevalonate Improves Anti-Pd-1/pd-l1 Efficacy by Stabilizing CD274 Mrna’ [acta Pharmaceutica Sinica B 13 (2023) 2585–2600]

Wenxin Zhang,Xiaohui Pan,Yanjun Xu,Hongjie Guo,Mingming Zheng,Xi Chen,Honghai Wu,Fengming Luan,Qiaojun He,Ling Ding,Bo Yang

DOI: https://doi.org/10.1016/j.apsb.2023.07.023

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2023.04.002.].
Erratum: Whole-transcriptome analysis of aluminum-exposed rat hippocampus and identification of ceRNA networks to investigate neurotoxicity of Al

Chanting He,Xiaoyan Zhao,Yang Lei,Jisheng Nie,Xiaoting Lu,Jing Song,Linping Wang,Huan Li,Fangqu Liu,Yidan Zhang,Qiao Niu

DOI: https://doi.org/10.1016/j.omtn.2024.102232

2024-06-04

Abstract:[This corrects the article DOI: 10.1016/j.omtn.2021.11.010.].
Corrigendum to “central Angiotensin II‐induced Alzheimer‐like Tau Phosphorylation in Normal Rat Brains” [FEBS Lett. 586 (2012) 3737–3745]

Man Tian,Donglin Zhu,Wei Xie,Jingping Shi

DOI: https://doi.org/10.1016/j.febslet.2013.01.060

2013-01-01

FEBS Letters

Abstract:An unfortunate error occurred in the labelling of Figure 5A. The correct Figure 5 is:
Author correction to ‘Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers’ [Acta Pharmaceutica Sinica B 11 (2021) 355–372]

Tingting Jiang,Guan Wang,Yao Liu,Lu Feng,Meng Wang,Jie Liu,Yi Chen,Liang Ouyang

DOI: https://doi.org/10.1016/j.apsb.2022.02.028

IF: 14.903

2022-03-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.05.004.].

pharmacology & pharmacy
Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Zhilin Li,Hao Cai,Zhiqian Li,Long Ren,Xuelei Ma,Hongyan Zhu,Qiyong Gong,Hu Zhang,Zhongwei Gu,Kui Luo

DOI: https://doi.org/10.1016/j.bioactmat.2022.09.016

IF: 18.9

2023-04-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.028.].

engineering, biomedical,materials science, biomaterials

Author correction to ‘A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease’ [Acta Pharmaceutica Sinica B 12 (2021) 4032‒4044]

Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Correction: Application of Carbon-Based Nanomaterials in Alzheimer's Disease.

Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747]

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35

Corrigendum to “tanshinone IIA Alleviates CCL2-Induced Leaning Memory and Cognition Impairment in Rats: A Potential Therapeutic Approach for HIV-Associated Neurocognitive Disorder”

Corrigendum: Microglia Mediate the Occurrence and Development of Alzheimer's Disease Through Ligand-Receptor Axis Communication

Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471]

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Author Correction: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy

Author Correction to ‘mevalonate Improves Anti-Pd-1/pd-l1 Efficacy by Stabilizing CD274 Mrna’ [acta Pharmaceutica Sinica B 13 (2023) 2585–2600]

Erratum: Whole-transcriptome analysis of aluminum-exposed rat hippocampus and identification of ceRNA networks to investigate neurotoxicity of Al

Corrigendum to “central Angiotensin II‐induced Alzheimer‐like Tau Phosphorylation in Normal Rat Brains” [FEBS Lett. 586 (2012) 3737–3745]

Author correction to ‘Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers’ [Acta Pharmaceutica Sinica B 11 (2021) 355–372]

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]